A detailed history of Alpine Woods Capital Investors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpine Woods Capital Investors, LLC holds 2,517 shares of REGN stock, worth $1.8 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
2,517
Previous 4,169 39.63%
Holding current value
$1.8 Million
Previous $4.38 Million 39.63%
% of portfolio
0.42%
Previous 0.61%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1024.09 - $1201.76 $1.69 Million - $1.99 Million
-1,652 Reduced 39.63%
2,517 $2.65 Million
Q2 2024

Aug 06, 2024

BUY
$883.2 - $1071.19 $169,574 - $205,668
192 Added 4.83%
4,169 $4.38 Million
Q1 2024

May 01, 2024

SELL
$902.69 - $993.35 $3.16 Million - $3.48 Million
-3,501 Reduced 46.82%
3,977 $3.83 Million
Q4 2023

Jan 24, 2024

SELL
$775.18 - $881.7 $539,525 - $613,663
-696 Reduced 8.51%
7,478 $6.57 Million
Q3 2023

Nov 08, 2023

BUY
$692.45 - $844.37 $126,025 - $153,675
182 Added 2.28%
8,174 $6.73 Million
Q2 2023

Aug 02, 2023

BUY
$700.03 - $830.35 $1.07 Million - $1.27 Million
1,530 Added 23.68%
7,992 $5.74 Million
Q1 2023

May 08, 2023

BUY
$680.49 - $826.97 $1,360 - $1,653
2 Added 0.03%
6,462 $5.31 Million
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $619,065 - $672,124
-877 Reduced 11.95%
6,460 $4.66 Million
Q3 2022

Oct 31, 2022

BUY
$573.97 - $724.32 $286,985 - $362,160
500 Added 7.31%
7,337 $5.05 Million
Q2 2022

Aug 02, 2022

SELL
$548.35 - $738.84 $54,835 - $73,884
-100 Reduced 1.44%
6,837 $4.04 Million
Q4 2021

Feb 03, 2022

BUY
$543.48 - $670.97 $197,826 - $244,233
364 Added 5.54%
6,937 $4.38 Million
Q2 2021

Aug 09, 2021

SELL
$472.8 - $558.54 $119,145 - $140,752
-252 Reduced 3.69%
6,573 $3.67 Million
Q1 2021

May 11, 2021

SELL
$446.73 - $548.2 $44,673 - $54,820
-100 Reduced 1.44%
6,825 $3.23 Million
Q4 2020

Feb 01, 2021

BUY
$478.3 - $607.98 $234,367 - $297,910
490 Added 7.61%
6,925 $3.35 Million
Q3 2020

Nov 02, 2020

SELL
$544.75 - $658.21 $89,883 - $108,604
-165 Reduced 2.5%
6,435 $3.6 Million
Q2 2020

Aug 10, 2020

SELL
$493.32 - $643.92 $147,996 - $193,176
-300 Reduced 4.35%
6,600 $4.12 Million
Q1 2020

May 04, 2020

BUY
$336.18 - $494.43 $806,832 - $1.19 Million
2,400 Added 53.33%
6,900 $3.37 Million
Q4 2018

Feb 13, 2019

SELL
$335.82 - $403.04 $33,582 - $40,304
-100 Reduced 2.17%
4,500 $1.68 Million
Q3 2018

Nov 08, 2018

BUY
$351.14 - $408.51 $35,114 - $40,851
100 Added 2.22%
4,600 $1.86 Million
Q2 2018

Aug 09, 2018

BUY
$284.6 - $344.99 $426,900 - $517,485
1,500 Added 50.0%
4,500 $1.55 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $717,260 - $939,900
2,000 Added 200.0%
3,000 $1.13 Million
Q3 2017

Nov 08, 2017

BUY
$431.38 - $504.0 $431,380 - $504,000
1,000
1,000 $447,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Alpine Woods Capital Investors, LLC Portfolio

Follow Alpine Woods Capital Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.